# Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV

> **NCT01603875** · NA · COMPLETED · sponsor: **Queen Saovabha Memorial Institute** · enrollment: 105 (actual)

## Conditions studied

- Efficacy of the New CPRV

## Interventions

- **BIOLOGICAL:** New Chromatographically Purified Vero-cell Rabies vaccine(new CPRV).

## Key facts

- **NCT ID:** NCT01603875
- **Lead sponsor:** Queen Saovabha Memorial Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-10
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603875, "Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01603875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*